T1	Intervention 629 748	assayed by real-time PCR in DNA extracted from whole blood (n = 2,834) and compared with paired tumor tissue (n = 977).
T2	Intervention 749 887	Ï‡(2) and two-sample t tests were used to compare baseline factors and KRAS mutation status between patients defined by LCS6 variant status
T3	Intervention 889 995	Log-rank tests and multivariate Cox models assessed associations between LCS6 status and DFS, respectively
